Allergan Aesthetics to acquire Soliton for body contouring technology

Allergan Aesthetics, an AbbVie company, announced a definitive agreement to acquire Soliton and its RESONIC Rapid Acoustic Pulse device, a non-invasive treatment for cellulite. The acquisition expands Allergan Aesthetics' body contouring portfolio.

“The acquisition of Soliton expands and complements Allergan Aesthetics' Body Contouring treatment portfolio which includes CoolSculpting® Elite.”nasdaq.com

• 1 source
• nasdaq.comAllergan Aesthetics to Acquire Soliton, Expanding Body Contouring Portfolio | NasdaqMay 10, 2021

Summarized from public sources; check the original articles before acting on it.